chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 62.0
Sex: F
Vaccine: COVID19
Symptoms: Disturbance in attention, Epistaxis, Feeling abnormal, Nausea, Pain in extremity
Clinical narrative: inability to concentrate/focus; nose bleeds; Sore arm; nausea; overall feeling of out of sorts coming in waves; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  An adult female patient (not pregnant) received bnt162b2 (BNT162B2), administered in arm left, administration date 13Aug2021 (Lot number: EW 0168) at the age of 62 years as dose 1, single for covid-19 immunisation. Relevant medical history included: "High blood pressure" (unspecified if ongoing). Concomitant medication(s) included: LISINOPRIL taken for hypertension; METOPROLOL taken for hypertension. Past drug history included: Iodine for Known allergies, notes: Iodine. The following information was reported: DISTURBANCE IN ATTENTION (non-serious) with onset 13Aug2021 18:00, outcome "recovering", described as "inability to concentrate/focus"; EPISTAXIS (non-serious) with onset 13Aug2021 18:00, outcome "recovering", described as "nose bleeds"; PAIN IN EXTREMITY (non-serious) with onset 13Aug2021 18:00, outcome "recovering", described as "Sore arm"; NAUSEA (non-serious) with onset 13Aug2021 18:00, outcome "recovering", described as "nausea"; FEELING ABNORMAL (non-serious) with onset 13Aug2021 18:00, outcome "recovering", described as "overall feeling of out of sorts coming in waves". Therapeutic measures were not taken as a result of disturbance in attention, epistaxis, pain in extremity, nausea, feeling abnormal.  Additional information: Patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Prior to vaccination, the patient had not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. Facility COVID-19 vaccine was administered at Doctor's office/urgent care.  No follow-up attempts are possible. No further information is expected.
Sex: M
Vaccine: COVID19
Symptoms: Chills, Myalgia, Pain, Pyrexia, Vomiting
Clinical narrative: This is a spontaneous report received from a non-contactable consumer or other non-HCP. A male patient received unknown dose number of BNT162B2 (Comirnaty, batch/lot# unknown), on Aug 16, 2021, single dose, for COVID-19 immunisation. The patient's medical history and concomitant medications not reported. The patient experienced vomiting/woke up vomiting, pain/progressed body ache, pyrexia/fever, chills and myalgia/muscle ache; all onset Aug 16, 2021, with outcome of not recovered. No follow-up attempts possible. Information about batch/lot number cannot be obtained. No further information expected.
Age: 44.0
Sex: F
Vaccine: COVID19
Symptoms: Erythema, Pain in extremity, Pruritus, Rash
Clinical narrative: puffy red rash across my cheeks; my face got a puffy red rash across my cheeks; along with the customary arm pain; my entire body was itchy for 2 days after the shot; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 44 year-old female patient (not pregnant) received bnt162b2 (BNT162B2), administered in arm left, administration date 11Aug2021 11:45 (Lot number: FC3180) at the age of 44 years as dose 1, single for covid-19 immunisation. Relevant medical history included: "None. Occasional seasonal allergy to pollen." (unspecified if ongoing). Concomitant medication(s) included: CLARITIN ALLERGIC; PROBIOTIC 10. Past drug history included: Nickel, reaction(s): "Known allergies: Nickel (skin allergy)", notes: Nickel (skin allergy).; Whey protein, reaction(s): "Known allergies: Whey protien"; Lactose, reaction(s): "Known allergies: lactose".The following information was reported: RASH (non-serious) with onset 12Aug2021 12:00, outcome "recovered", described as "puffy red rash across my cheeks"; ERYTHEMA (non-serious) with onset 12Aug2021 12:00, outcome "recovered", described as "my face got a puffy red rash across my cheeks"; PAIN IN EXTREMITY (non-serious) with onset 12Aug2021 12:00, outcome "recovered", described as "along with the customary arm pain"; PRURITUS (non-serious) with onset 12Aug2021 12:00, outcome "recovered", described as "my entire body was itchy for 2 days after the shot". Therapeutic measures were taken as a result of rash, erythema, pain in extremity, pruritus with Claritin.  Additional information: Patient not receive any other vaccine in four weeks. Patient self-administered AE treatment Otc allergy meds. Prior vaccination patient not tested covid positive, post vaccination patient did not tested covid positive.  No follow-up attempts are possible. No further information is expected.
Age: 32.0
Sex: M
Vaccine: COVID19
Symptoms: Eyelid pain, Pain assessment, Swelling of eyelid
Clinical narrative: Woke up next morning with right upper eyelid swollen to the point I could barely open my right eye.; Approx. 5 hours post vaccination, my right upper eyelid began to hurt, continued up to a 7/10 pain scale.; This is a spontaneous report received from a contactable reporter(s) (Other HCP). The reporter is the patient.  A 32 year-old male patient received bnt162b2 (BNT162B2), administered in arm left, administration date 17Aug2021 12:30 (Lot number: EW0168) at the age of 32 years as dose 1, single for covid-19 immunisation. Relevant medical history included: "Psoriasis" (unspecified if ongoing); "Psoriasis/Psoriatic Arthritis" (unspecified if ongoing); "Crohn's/Colitis" (unspecified if ongoing); "Crohn's/Colitis" (unspecified if ongoing); "Thyroid Cancer" (unspecified if ongoing). Concomitant medication(s) included: LEVOTHYROXINE; AVSOLA [INFLIXIMAB]; FLUVOXAMINE; AMITIZA. The following information was reported: EYELID PAIN (non-serious) with onset 17Aug2021 17:30, outcome "recovering", described as "Approx. 5 hours post vaccination, my right upper eyelid began to hurt, continued up to a 7/10 pain scale."; SWELLING OF EYELID (non-serious) with onset 18Aug2021, outcome "recovering", described as "Woke up next morning with right upper eyelid swollen to the point I could barely open my right eye.". Relevant laboratory tests and procedures are available in the appropriate section. Therapeutic measures were not taken as a result of eyelid pain, swelling of eyelid.  Additional information: no other vaccine in four weeks. No covid prior vaccination. No covid tested post vaccination. No Known allergies.  No follow-up attempts are possible. No further information is expected.
Age: 58.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Blood pressure increased, Electrocardiogram, Hypoaesthesia, Pain in extremity
Clinical narrative: stated that she had left arm pain down to her wrists; stated that she had left arm pain down to her wrists; stated that her fingers were tingling and numb (left); stated that her fingers were tingling and numb (left); ." Caller reports her blood pressure "really going up"; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) from medical information team. The reporter is the patient.  A 58 year-old female patient received bnt162b2 (BNT162B2), administered in arm left, administration date 29Jul2021 (Lot number: FA7484) at the age of 58 years as dose 1, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: ARTHRALGIA (non-serious), PAIN IN EXTREMITY (non-serious) all with onset 01Aug2021, outcome "recovering" and all described as "stated that she had left arm pain down to her wrists"; HYPOAESTHESIA (non-serious), PARAESTHESIA (non-serious) all with onset 01Aug2021, outcome "recovering" and all described as "stated that her fingers were tingling and numb (left)"; BLOOD PRESSURE INCREASED (non-serious) with onset 2021, outcome "unknown", described as "." Caller reports her blood pressure "really going up"". Relevant laboratory tests and procedures are available in the appropriate section. Therapeutic measures were not taken as a result of arthralgia, pain in extremity, hypoaesthesia, paraesthesia, blood pressure increased.  Clinical Course: Caller received her 1st dose of the Pfizer COVID-19 Vaccination. She received her 1st dose on 29Jul2021 and was scheduled to have her 2nd dose day after. 3 days after receiving the 1st dose, the caller reports having left arm pain, down to her wrist and also notes her fingers were tingling and numb. The patient did go to her HCP who advised that the symptoms she was presenting with could be due to the vaccine administrator hitting a nerve and did expect the side effects to resolve within a few days. He advised that further neurology referral would be necessary if patient's symptoms did not resolve. The caller was now very hesitant to get the 2nd dose of the vaccine due to the "side effects" she has encountered and wants to know why she got these side effects. Caller had an EKG done when she was seen by her HCP for the numbness and tingling she was experiencing and the results were normal and her heart was said to be "good." Caller reports her blood pressure "really going up" thus what prompted the EKG study.  No follow-up attempts are possible. No further information is expected.
Age: 58.0
Sex: F
Vaccine: COVID19
Symptoms: Paraesthesia
Clinical narrative: stated that she had left arm pain down to her wrists; stated that she had left arm pain down to her wrists; stated that her fingers were tingling and numb (left); stated that her fingers were tingling and numb (left); ." Caller reports her blood pressure "really going up"; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) from medical information team. The reporter is the patient.  A 58 year-old female patient received bnt162b2 (BNT162B2), administered in arm left, administration date 29Jul2021 (Lot number: FA7484) at the age of 58 years as dose 1, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: ARTHRALGIA (non-serious), PAIN IN EXTREMITY (non-serious) all with onset 01Aug2021, outcome "recovering" and all described as "stated that she had left arm pain down to her wrists"; HYPOAESTHESIA (non-serious), PARAESTHESIA (non-serious) all with onset 01Aug2021, outcome "recovering" and all described as "stated that her fingers were tingling and numb (left)"; BLOOD PRESSURE INCREASED (non-serious) with onset 2021, outcome "unknown", described as "." Caller reports her blood pressure "really going up"". Relevant laboratory tests and procedures are available in the appropriate section. Therapeutic measures were not taken as a result of arthralgia, pain in extremity, hypoaesthesia, paraesthesia, blood pressure increased.  Clinical Course: Caller received her 1st dose of the Pfizer COVID-19 Vaccination. She received her 1st dose on 29Jul2021 and was scheduled to have her 2nd dose day after. 3 days after receiving the 1st dose, the caller reports having left arm pain, down to her wrist and also notes her fingers were tingling and numb. The patient did go to her HCP who advised that the symptoms she was presenting with could be due to the vaccine administrator hitting a nerve and did expect the side effects to resolve within a few days. He advised that further neurology referral would be necessary if patient's symptoms did not resolve. The caller was now very hesitant to get the 2nd dose of the vaccine due to the "side effects" she has encountered and wants to know why she got these side effects. Caller had an EKG done when she was seen by her HCP for the numbness and tingling she was experiencing and the results were normal and her heart was said to be "good." Caller reports her blood pressure "really going up" thus what prompted the EKG study.  No follow-up attempts are possible. No further information is expected.
Age: 47.0
Sex: F
Vaccine: COVID19
Symptoms: Blister, Rash
Clinical narrative: I had the 1st shot in my right arm. However, I developed a very small rash in the crease of my LEFT arm; a few slight bumps in the crease of the right arm within a week of the 1st shot.; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 47 year-old female patient (not pregnant) received bnt162b2 (BNT162B2), administered in arm right, administration date 26Jun2021 14:15 (Lot number: EW0181) at the age of 47 years as dose 1, single for covid-19 immunisation. Relevant medical history included: "Anemia" (unspecified if ongoing), notes: Anemia (I'm vegetarian), some history of high blood pressure; "High blood pressure" (unspecified if ongoing), notes: Anemia (I'm vegetarian), some history of high blood pressure. Concomitant medication(s) included: IRON. Past drug history included: Isoniazid, reaction(s): "Known Allergies: Isoniazid". The following information was reported: RASH (non-serious) with onset 2021, outcome "recovered" (2021), described as "I had the 1st shot in my right arm. However, I developed a very small rash in the crease of my LEFT arm"; BLISTER (non-serious) with onset 2021, outcome "recovered" (2021), described as "a few slight bumps in the crease of the right arm within a week of the 1st shot.". Therapeutic measures were not taken as a result of rash, blister.  Additional information: She had the 2nd shot in the left arm. This time, She did not develop any rash in the right arm, but about one to two weeks after the 2nd shot, she noticed the area on her left arm had become dark in the same place where the 1st rash presented. Over the next few days, that area became red, itchy & inflamed. It started out as a dark spot about the size of a dime & grew in size to cover the entire arm crease and an area 1.25 inches above and below the crease. Initially, she put 91% alcohol & iodine on it to prevent an infection & left it alone, thinking it would go away just like the 1st rash did after the 1st shot. However, this 2nd rash had become more pronounced & she realized she needed to inform someone. Adverse event start date was reported as 09Aug2021. No covid prior vaccination. Covid was not tested post vaccination.  No follow-up attempts are possible. No further information is expected.
Sex: F
Vaccine: COVID19
Symptoms: Dizziness, Dyspnoea, Headache, Nausea, Rash
Clinical narrative: Dizziness immediately after getting/lightheaded; Headache immediately after getting; Rash up arm and across chest; having difficulty breathing; nausea; vomited a little bit, just clear liquid; This is a spontaneous report received from a contactable reporter(s) (Pharmacist) from medical information team.  A female patient received bnt162b2 (BNT162B2) (Lot number: FC 3181, Expiration Date: 31Oct2021) as dose number unknown, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: DIZZINESS (non-serious), outcome "unknown", described as "Dizziness immediately after getting/lightheaded"; HEADACHE (non-serious), outcome "unknown", described as "Headache immediately after getting"; RASH (non-serious), outcome "unknown", described as "Rash up arm and across chest"; DYSPNOEA (non-serious), outcome "unknown", described as "having difficulty breathing"; NAUSEA (non-serious), outcome "unknown", described as "nausea"; VOMITING (non-serious), outcome "unknown", described as "vomited a little bit, just clear liquid".  Additional information: A pharmacist noticed a few side effects from 4 patients in one week that were all the same and were coming from the same Lot FC3181. Four people have had same or similar side effects with a same batch headache immediately, dizziness immediately, rash going up the arm and across the chest, all within this last week. A female within 5 minutes had dizziness and lightheaded, she started having difficulty breathing, all vitals were good, also had nausea and vomited a little bit, just clear liquid. No further details provided.  Follow-up attempts are completed. No further information is expected; Sender's Comments: Linked Report(s) : US-PFIZER INC-202101070497 Same reporter/drug, different patient/similar AE;US-PFIZER INC-202101070496 same reporter/drug, different patient/similar AE;US-PFIZER INC-202101070495 Same reporter/drug, different patient/similar AE
Sex: F
Vaccine: COVID19
Symptoms: Vomiting
Clinical narrative: Dizziness immediately after getting/lightheaded; Headache immediately after getting; Rash up arm and across chest; having difficulty breathing; nausea; vomited a little bit, just clear liquid; This is a spontaneous report received from a contactable reporter(s) (Pharmacist) from medical information team.  A female patient received bnt162b2 (BNT162B2) (Lot number: FC 3181, Expiration Date: 31Oct2021) as dose number unknown, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: DIZZINESS (non-serious), outcome "unknown", described as "Dizziness immediately after getting/lightheaded"; HEADACHE (non-serious), outcome "unknown", described as "Headache immediately after getting"; RASH (non-serious), outcome "unknown", described as "Rash up arm and across chest"; DYSPNOEA (non-serious), outcome "unknown", described as "having difficulty breathing"; NAUSEA (non-serious), outcome "unknown", described as "nausea"; VOMITING (non-serious), outcome "unknown", described as "vomited a little bit, just clear liquid".  Additional information: A pharmacist noticed a few side effects from 4 patients in one week that were all the same and were coming from the same Lot FC3181. Four people have had same or similar side effects with a same batch headache immediately, dizziness immediately, rash going up the arm and across the chest, all within this last week. A female within 5 minutes had dizziness and lightheaded, she started having difficulty breathing, all vitals were good, also had nausea and vomited a little bit, just clear liquid. No further details provided.  Follow-up attempts are completed. No further information is expected; Sender's Comments: Linked Report(s) : US-PFIZER INC-202101070497 Same reporter/drug, different patient/similar AE;US-PFIZER INC-202101070496 same reporter/drug, different patient/similar AE;US-PFIZER INC-202101070495 Same reporter/drug, different patient/similar AE
Age: 47.0
Sex: F
Vaccine: COVID19
Symptoms: Erythema, Inflammation, Pruritus, Rash, Rash macular
Clinical narrative: I noticed the area on my Left arm had become dark in the same place where the 1st rash presented.; Over the next few days, that area became red, itchy & inflamed; Over the next few days, that area became red, itchy & inflamed; Over the next few days, that area became red, itchy & inflamed; It started out as a dark spot about the size of a dime & grew in size to cover the entire arm crease and an area 1.25 inches above and below the crease; This 2nd rash has become more pronounced & I realized I needed to inform someone.; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 47 year-old female patient (not pregnant) received bnt162b2 (BNT162B2), administered in arm left, administration date 18Jul2021 16:30 (Lot number: FA7484) at the age of 47 years as dose 2, single for covid-19 immunisation. Relevant medical history included: "Anemia" (unspecified if ongoing); "High blood pressure" (unspecified if ongoing). Concomitant medication(s) included: IRON. Past drug history included: Isoniazid, reaction(s): "known allergies: Isoniazid". Vaccination history included: Bnt162b2 (Dose: 1, Lot number: EW0181, Administration date: 26Jun2021, time: 14:15, Vaccine location: right arm), administration date: 26Jun2021, when the patient was 47 years old, for Covid-19 immunisation, reaction(s): "I developed a very small rash in the crease of my Left arm", "few slight bumps in the crease of the right arm". The following information was reported: SKIN DISCOLOURATION (non-serious) with onset 09Aug2021, outcome "not recovered", described as "I noticed the area on my Left arm had become dark in the same place where the 1st rash presented."; INFLAMMATION (non-serious), ERYTHEMA (non-serious), PRURITUS (non-serious) all with onset 09Aug2021, outcome "not recovered" and all described as "Over the next few days, that area became red, itchy & inflamed"; RASH MACULAR (non-serious) with onset 09Aug2021, outcome "not recovered", described as "It started out as a dark spot about the size of a dime & grew in size to cover the entire arm crease and an area 1.25 inches above and below the crease"; RASH (non-serious) with onset 09Aug2021, outcome "not recovered", described as "This 2nd rash has become more pronounced & I realized I needed to inform someone.". Therapeutic measures were taken as a result of skin discolouration, inflammation, erythema, pruritus, rash macular, rash.  Additional information: Initially, patient had put on 91 percent alcohol & iodine on it to prevent an infection and left it alone, thinking it would go away just like the 1st rash did after the 1st shot. However, this 2nd rash has become more. Patient had no covid prior to vaccination. Patient had not tested covid post vaccination.  No follow-up attempts are possible. No further information is expected.
Age: 47.0
Sex: F
Vaccine: COVID19
Symptoms: Skin discolouration
Clinical narrative: I noticed the area on my Left arm had become dark in the same place where the 1st rash presented.; Over the next few days, that area became red, itchy & inflamed; Over the next few days, that area became red, itchy & inflamed; Over the next few days, that area became red, itchy & inflamed; It started out as a dark spot about the size of a dime & grew in size to cover the entire arm crease and an area 1.25 inches above and below the crease; This 2nd rash has become more pronounced & I realized I needed to inform someone.; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 47 year-old female patient (not pregnant) received bnt162b2 (BNT162B2), administered in arm left, administration date 18Jul2021 16:30 (Lot number: FA7484) at the age of 47 years as dose 2, single for covid-19 immunisation. Relevant medical history included: "Anemia" (unspecified if ongoing); "High blood pressure" (unspecified if ongoing). Concomitant medication(s) included: IRON. Past drug history included: Isoniazid, reaction(s): "known allergies: Isoniazid". Vaccination history included: Bnt162b2 (Dose: 1, Lot number: EW0181, Administration date: 26Jun2021, time: 14:15, Vaccine location: right arm), administration date: 26Jun2021, when the patient was 47 years old, for Covid-19 immunisation, reaction(s): "I developed a very small rash in the crease of my Left arm", "few slight bumps in the crease of the right arm". The following information was reported: SKIN DISCOLOURATION (non-serious) with onset 09Aug2021, outcome "not recovered", described as "I noticed the area on my Left arm had become dark in the same place where the 1st rash presented."; INFLAMMATION (non-serious), ERYTHEMA (non-serious), PRURITUS (non-serious) all with onset 09Aug2021, outcome "not recovered" and all described as "Over the next few days, that area became red, itchy & inflamed"; RASH MACULAR (non-serious) with onset 09Aug2021, outcome "not recovered", described as "It started out as a dark spot about the size of a dime & grew in size to cover the entire arm crease and an area 1.25 inches above and below the crease"; RASH (non-serious) with onset 09Aug2021, outcome "not recovered", described as "This 2nd rash has become more pronounced & I realized I needed to inform someone.". Therapeutic measures were taken as a result of skin discolouration, inflammation, erythema, pruritus, rash macular, rash.  Additional information: Initially, patient had put on 91 percent alcohol & iodine on it to prevent an infection and left it alone, thinking it would go away just like the 1st rash did after the 1st shot. However, this 2nd rash has become more. Patient had no covid prior to vaccination. Patient had not tested covid post vaccination.  No follow-up attempts are possible. No further information is expected.
Age: 32.0
Sex: F
Vaccine: COVID19
Symptoms: Asthenia, Chest X-ray, Chills, Heart rate increased, Laboratory test
Clinical narrative: nauseas; fevers; chills; generalize weakness; heart rate elevated; This is a spontaneous report received from a contactable reporter(s) (Other HCP). The reporter is the patient.  A 32 year-old female patient (not pregnant) received bnt162b2 (BNT162B2), administered in arm left, administration date 12Aug2021 17:15 (Lot number: FC3180) at the age of 32 years as dose 1, single for covid-19 immunisation. The patient had no relevant medical history. There were no concomitant medications. The following information was reported: NAUSEA (non-serious) with onset 13Aug2021 18:30, outcome "not recovered", described as "nauseas"; PYREXIA (non-serious) with onset 13Aug2021 18:30, outcome "not recovered", described as "fevers"; CHILLS (non-serious) with onset 13Aug2021 18:30, outcome "not recovered", described as "chills"; ASTHENIA (non-serious) with onset 13Aug2021 18:30, outcome "not recovered", described as "generalize weakness"; HEART RATE INCREASED (non-serious) with onset 13Aug2021 18:30, outcome "not recovered", described as "heart rate elevated". The events "nauseas", "fevers", "chills", "generalize weakness" and "heart rate elevated" were evaluated at the emergency room visit. Relevant laboratory tests and procedures are available in the appropriate section. Therapeutic measures were taken as a result of nausea, pyrexia, chills, asthenia, heart rate increased.  Additional information: Vaccination facility type was Pharmacy or Drug Store. Patient had no known allergies. The patient had neither received any other vaccine in four weeks prior to vaccination nor received any other medications within two weeks. The patient started experiencing symptoms on 13Aug2021 one day after getting the vaccine. However (today) 18Aug2021 was day 6th of having nauseas, fevers, chills and generalize weakness. The patient's heart rate had been elevated since Friday. She had to go to the Emergency department and urgent care since she did not feel okay. The patient took treatment for AE IV fluids, Tylenol and Motrin. No COVID prior vaccination.  No follow-up attempts are possible. No further information is expected.
Age: 32.0
Sex: F
Vaccine: COVID19
Symptoms: Nausea, Pyrexia, SARS-CoV-2 test
Clinical narrative: nauseas; fevers; chills; generalize weakness; heart rate elevated; This is a spontaneous report received from a contactable reporter(s) (Other HCP). The reporter is the patient.  A 32 year-old female patient (not pregnant) received bnt162b2 (BNT162B2), administered in arm left, administration date 12Aug2021 17:15 (Lot number: FC3180) at the age of 32 years as dose 1, single for covid-19 immunisation. The patient had no relevant medical history. There were no concomitant medications. The following information was reported: NAUSEA (non-serious) with onset 13Aug2021 18:30, outcome "not recovered", described as "nauseas"; PYREXIA (non-serious) with onset 13Aug2021 18:30, outcome "not recovered", described as "fevers"; CHILLS (non-serious) with onset 13Aug2021 18:30, outcome "not recovered", described as "chills"; ASTHENIA (non-serious) with onset 13Aug2021 18:30, outcome "not recovered", described as "generalize weakness"; HEART RATE INCREASED (non-serious) with onset 13Aug2021 18:30, outcome "not recovered", described as "heart rate elevated". The events "nauseas", "fevers", "chills", "generalize weakness" and "heart rate elevated" were evaluated at the emergency room visit. Relevant laboratory tests and procedures are available in the appropriate section. Therapeutic measures were taken as a result of nausea, pyrexia, chills, asthenia, heart rate increased.  Additional information: Vaccination facility type was Pharmacy or Drug Store. Patient had no known allergies. The patient had neither received any other vaccine in four weeks prior to vaccination nor received any other medications within two weeks. The patient started experiencing symptoms on 13Aug2021 one day after getting the vaccine. However (today) 18Aug2021 was day 6th of having nauseas, fevers, chills and generalize weakness. The patient's heart rate had been elevated since Friday. She had to go to the Emergency department and urgent care since she did not feel okay. The patient took treatment for AE IV fluids, Tylenol and Motrin. No COVID prior vaccination.  No follow-up attempts are possible. No further information is expected.
Age: 34.0
Sex: F
Vaccine: COVID19
Symptoms: Dizziness, Dyspnoea, Headache, SARS-CoV-2 test, Urticaria
Clinical narrative: Hives; shortness of breath; dizziness; headache; This is a spontaneous report received from contactable reporter(s) nurse (Other HCP). The reporter is the patient.  A 34 year-old female patient (not pregnant) received bnt162b2 (BNT162B2), administered in arm left, administration date 16Aug2021 15:30 (Lot number: Ew0176) at the age of 34 years as dose 1, single for covid-19 immunisation. The patient's relevant medical history was not reported. There were no concomitant medications. The following information was reported: URTICARIA (non-serious) with onset 16Aug2021, outcome "recovering", described as "Hives"; DYSPNOEA (non-serious) with onset 16Aug2021, outcome "recovering", described as "shortness of breath"; DIZZINESS (non-serious) with onset 16Aug2021, outcome "recovering", described as "dizziness"; HEADACHE (non-serious) with onset 16Aug2021, outcome "recovering", described as "headache". Relevant laboratory tests and procedures are available in the appropriate section. Therapeutic measures were not taken as a result of urticaria, dyspnoea, dizziness, headache.  Additional information: Facility where COVID-19 vaccine was administered Pharmacy or Drug Store. The patient did not receive any other vaccine in four weeks prior to the COVID vaccine. Patient did not receive any other medications in two weeks. Prior to vaccination, the patient was not diagnosed with COVID-19. Post vaccination, the patient had been tested for COVID-19 with Nasal Swab resulted negative on 17Aug2021.  No follow-up attempts are possible. No further information is expected.
Age: 38.0
Sex: F
Vaccine: COVID19
Symptoms: Abdominal discomfort, Chills, Dizziness, Fatigue, Headache
Clinical narrative: Head ache; Dizzy; Chills; Fever; Exhaustion; Body aches; Upset stomach; This is a spontaneous report received from a contactable reporter(s) (Other HCP). The reporter is the patient.  A 38 year-old female patient (not pregnant) received bnt162b2 (BNT162B2), intramuscular, administered in arm right, administration date 08Aug2021 14:00 (Lot number: FC3180) at the age of 38 years as dose 1, single for covid-19 immunisation. Relevant medical history included: "Covid-19" (unspecified if ongoing). There were no concomitant medications. The following information was reported: HEADACHE (non-serious) with onset 08Aug2021 19:00, outcome "recovered with sequelae" (2021), described as "Head ache"; DIZZINESS (non-serious) with onset 08Aug2021 19:00, outcome "recovered with sequelae" (2021), described as "Dizzy"; CHILLS (non-serious) with onset 08Aug2021 19:00, outcome "recovered with sequelae" (2021), described as "Chills"; PYREXIA (non-serious) with onset 08Aug2021 19:00, outcome "recovered with sequelae" (2021), described as "Fever"; FATIGUE (non-serious) with onset 08Aug2021 19:00, outcome "recovered with sequelae" (2021), described as "Exhaustion"; PAIN (non-serious) with onset 08Aug2021 19:00, outcome "recovered with sequelae" (2021), described as "Body aches"; ABDOMINAL DISCOMFORT (non-serious) with onset 08Aug2021 19:00, outcome "recovered with sequelae" (2021), described as "Upset stomach". Therapeutic measures were not taken as a result of headache, dizziness, chills, pyrexia, fatigue, pain, abdominal discomfort.  Additional information: Facility where the most recent COVID-19 vaccine was administered: Pharmacy or Drug Store. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Any other medications the patient received within 2 weeks of vaccination: None. Ae resulted in none of the above. If patient recovered: Recovering with lasting effects. Prior to vaccination, the patient was diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. Device Date was 18Aug2021.  Follow-Up (27Aug2021): Follow-up attempts are completed. No further information is expected.
Age: 38.0
Sex: F
Vaccine: COVID19
Symptoms: Pain, Pyrexia
Clinical narrative: Head ache; Dizzy; Chills; Fever; Exhaustion; Body aches; Upset stomach; This is a spontaneous report received from a contactable reporter(s) (Other HCP). The reporter is the patient.  A 38 year-old female patient (not pregnant) received bnt162b2 (BNT162B2), intramuscular, administered in arm right, administration date 08Aug2021 14:00 (Lot number: FC3180) at the age of 38 years as dose 1, single for covid-19 immunisation. Relevant medical history included: "Covid-19" (unspecified if ongoing). There were no concomitant medications. The following information was reported: HEADACHE (non-serious) with onset 08Aug2021 19:00, outcome "recovered with sequelae" (2021), described as "Head ache"; DIZZINESS (non-serious) with onset 08Aug2021 19:00, outcome "recovered with sequelae" (2021), described as "Dizzy"; CHILLS (non-serious) with onset 08Aug2021 19:00, outcome "recovered with sequelae" (2021), described as "Chills"; PYREXIA (non-serious) with onset 08Aug2021 19:00, outcome "recovered with sequelae" (2021), described as "Fever"; FATIGUE (non-serious) with onset 08Aug2021 19:00, outcome "recovered with sequelae" (2021), described as "Exhaustion"; PAIN (non-serious) with onset 08Aug2021 19:00, outcome "recovered with sequelae" (2021), described as "Body aches"; ABDOMINAL DISCOMFORT (non-serious) with onset 08Aug2021 19:00, outcome "recovered with sequelae" (2021), described as "Upset stomach". Therapeutic measures were not taken as a result of headache, dizziness, chills, pyrexia, fatigue, pain, abdominal discomfort.  Additional information: Facility where the most recent COVID-19 vaccine was administered: Pharmacy or Drug Store. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Any other medications the patient received within 2 weeks of vaccination: None. Ae resulted in none of the above. If patient recovered: Recovering with lasting effects. Prior to vaccination, the patient was diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. Device Date was 18Aug2021.  Follow-Up (27Aug2021): Follow-up attempts are completed. No further information is expected.
Sex: M
Vaccine: COVID19
Symptoms: Pruritus, SARS-CoV-2 test
Clinical narrative: My forearms are itchy.; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 46 year-old male patient received bnt162b2 (BNT162B2), administered in arm left, administration date 26Feb2021 16:00 (Lot number: EL9263) as dose 1, single for covid-19 immunisation. The patient received bnt162b2 (BNT162B2), administered in arm right, administration date 19Mar2021 08:00 (Lot number: EN6198) as dose 2, single for covid-19 immunization. The patient's relevant medical history and concomitant medications were not reported. Past drug history included: Amox, notes: Amox. The following information was reported: PRURITUS (non-serious) with onset 01Mar2021 18:00, outcome "not recovered", described as "My forearms are itchy.". Relevant laboratory tests and procedures are available in the appropriate section. Therapeutic measures were not taken as a result of pruritus.  Additional information: He noticed this when he was unoccupied, particularly in the evening and night. Patient did not have covid prior vaccination. Patient tested for covid post vaccination. Patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine.   No follow-up attempts are possible. No further information is expected.
Sex: F
Vaccine: COVID19
Symptoms: Dizziness, Headache, Rash
Clinical narrative: Dizziness immediately after getting; Headache immediately after getting/ experienced headache behind her eyes; Rash up arm and across chest; This is a spontaneous report received from a contactable reporter(s) (Pharmacist) from medical information team.  This is 2nd of 4th case.  A female patient received bnt162b2 (BNT162B2) (Lot number: FC3181, Expiration Date: 31Oct2021) as dose number unknown, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: DIZZINESS (non-serious), outcome "unknown", described as "Dizziness immediately after getting"; HEADACHE (non-serious), outcome "unknown", described as "Headache immediately after getting/ experienced headache behind her eyes"; RASH (non-serious), outcome "unknown", described as "Rash up arm and across chest".  Additional information: Received call from pharmacist regarding the Pfizer COVID vaccine.  She is a pharmacist at (Pharmacy name) and has noticed a few side effects from 4 patients in one week that are all the same and are coming from the same Lot FC3181.  She is wondering if Pfizer would recommend she quarantine the batch.  She has given over 200 out of that batch.  She did not have any patient information to provide today and requested to be transferred to have her question answered.  She completed VAERS reports for the patients. She stated she will go online and use the QR code to complete Pfizer reports as well. She is just trying to see if she should keep giving.    No follow-up attempts are possible. No further information is expected.; Sender's Comments: Linked Report(s) : US-PFIZER INC-202101069070 Same reporter/drug, different patient/similar AE
Sex: U
Vaccine: COVID19
Symptoms: Dizziness, Headache, Rash, Vaccination site rash
Clinical narrative: Dizziness immediately after getting; Headache immediately after getting; Rash up arm and across chest; a rash across the chest and in the vaccinated arm; This is a spontaneous report received from a contactable reporter(s) (Pharmacist) from medical information team.  A patient (no qualifiers provided) received bnt162b2 (BNT162B2), administered in arm, administration date Aug2021 (Lot number: FC3181, Expiration Date: 31Oct2021) as dose number unknown, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: DIZZINESS (non-serious) with onset Aug2021, outcome "unknown", described as "Dizziness immediately after getting"; HEADACHE (non-serious) with onset Aug2021, outcome "unknown", described as "Headache immediately after getting"; RASH (non-serious) with onset Aug2021, outcome "unknown", described as "Rash up arm and across chest"; VACCINATION SITE RASH (non-serious) with onset Aug2021, outcome "unknown", described as "a rash across the chest and in the vaccinated arm".  Follow-up attempts are completed. No further information is expected.  ; Sender's Comments: Linked Report(s) : US-PFIZER INC-202101069070 Same reporter/drug, different patient/similar AE
Age: 47.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Fatigue, Headache, Myalgia, Pain
Clinical narrative: Body Aches (muscle and joint); Body Aches (muscle and joint); Body Aches (muscle and joint); headache; Fatigue; Tenderness at injection site; Fever; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 47 year-old female patient (not pregnant) received bnt162b2 (BNT162B2), administered in arm right, administration date 17Aug2021 17:00 (Lot number: EW0198) at the age of 47 years as dose 2, single for covid-19 immunisation. Relevant medical history included: "High Blood Pressure" (unspecified if ongoing), notes: Verbatim: High Blood Pressure; "Heart Murmur" (unspecified if ongoing). Concomitant medication(s) included: LISINOPRIL; ERRIN [ERYTHROMYCIN]. Vaccination history included: Bnt162b2 (Dose number: 1, Administration time: 06:00 PM, Vaccine location: Right Arm, Lot number:FA6780), administration date: 27Jul2021, when the patient was 47 years old, for Covid-19 Immunization. The following information was reported: PAIN (non-serious), MYALGIA (non-serious), ARTHRALGIA (non-serious) all with onset 18Aug2021 10:00, outcome "unknown" and all described as "Body Aches (muscle and joint)"; HEADACHE (non-serious) with onset 18Aug2021 10:00, outcome "unknown", described as "headache"; FATIGUE (non-serious) with onset 18Aug2021 10:00, outcome "unknown", described as "Fatigue"; VACCINATION SITE PAIN (non-serious) with onset 18Aug2021 10:00, outcome "unknown", described as "Tenderness at injection site"; PYREXIA (non-serious) with onset 18Aug2021 10:00, outcome "unknown", described as "Fever". Therapeutic measures were not taken as a result of pain, myalgia, arthralgia, headache, fatigue, vaccination site pain, pyrexia.  Additional information: Patient had no known allergies. The most recent COVID-19 vaccine was administered at Public Health Clinic/Veterans Administration facility. the patient did not received any other vaccines within 4 weeks prior to the COVID vaccine. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19.   No follow-up attempts are possible. No further information is expected.
Age: 47.0
Sex: F
Vaccine: COVID19
Symptoms: Pyrexia, Vaccination site pain
Clinical narrative: Body Aches (muscle and joint); Body Aches (muscle and joint); Body Aches (muscle and joint); headache; Fatigue; Tenderness at injection site; Fever; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 47 year-old female patient (not pregnant) received bnt162b2 (BNT162B2), administered in arm right, administration date 17Aug2021 17:00 (Lot number: EW0198) at the age of 47 years as dose 2, single for covid-19 immunisation. Relevant medical history included: "High Blood Pressure" (unspecified if ongoing), notes: Verbatim: High Blood Pressure; "Heart Murmur" (unspecified if ongoing). Concomitant medication(s) included: LISINOPRIL; ERRIN [ERYTHROMYCIN]. Vaccination history included: Bnt162b2 (Dose number: 1, Administration time: 06:00 PM, Vaccine location: Right Arm, Lot number:FA6780), administration date: 27Jul2021, when the patient was 47 years old, for Covid-19 Immunization. The following information was reported: PAIN (non-serious), MYALGIA (non-serious), ARTHRALGIA (non-serious) all with onset 18Aug2021 10:00, outcome "unknown" and all described as "Body Aches (muscle and joint)"; HEADACHE (non-serious) with onset 18Aug2021 10:00, outcome "unknown", described as "headache"; FATIGUE (non-serious) with onset 18Aug2021 10:00, outcome "unknown", described as "Fatigue"; VACCINATION SITE PAIN (non-serious) with onset 18Aug2021 10:00, outcome "unknown", described as "Tenderness at injection site"; PYREXIA (non-serious) with onset 18Aug2021 10:00, outcome "unknown", described as "Fever". Therapeutic measures were not taken as a result of pain, myalgia, arthralgia, headache, fatigue, vaccination site pain, pyrexia.  Additional information: Patient had no known allergies. The most recent COVID-19 vaccine was administered at Public Health Clinic/Veterans Administration facility. the patient did not received any other vaccines within 4 weeks prior to the COVID vaccine. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19.   No follow-up attempts are possible. No further information is expected.
Sex: U
Vaccine: COVID19
Symptoms: Body temperature, Feeling hot, Headache, Illness, Laboratory test
Clinical narrative: Terrific headache/bad headache; I got sick last night with nausea; I got sick last night; Feel running fever and right now at 99.2; hot burn; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A patient (no qualifiers provided) received bnt162b2 (BNT162B2), administration date 17Aug2021 08:45 (Lot number: LD8448) as dose 2, single for covid-19 immunisation. Relevant medical history included: "low immune system" (unspecified if ongoing). The patient took concomitant medications. Vaccination history included: Bnt162b2 (Dose 1, Lot number: EW0164), administration date: 27Jul2021, for COVID-19 immunization; Pneumonia shot 13, for Immunization, reaction(s): "I had no side effect for the pneumonia shot". The following information was reported: HEADACHE (non-serious), outcome "unknown", described as "Terrific headache/bad headache"; NAUSEA (non-serious), outcome "unknown", described as "I got sick last night with nausea"; ILLNESS (non-serious), outcome "unknown", described as "I got sick last night"; PYREXIA (non-serious), outcome "unknown", described as "Feel running fever and right now at 99.2"; FEELING HOT (non-serious), outcome "unknown", described as "hot burn". Relevant laboratory tests and procedures are available in the appropriate section. Therapeutic measures were taken as a result of headache, nausea, illness, pyrexia, feeling hot.  Additional information: The patient got the shot that day about 8:45, somewhere around there the patient started having terrific headache and got sick last night with nausea, felt running fever and right now at 99.2. The patient was in bed. The patient wanted to know if that was normal. The patient had a low immune system. The patient was running fever right now, got a bad headache, had nausea since last night off and on and hot burn and the patient's head just felt, head hurt but head felt little relaxed. The patient took Tylenol for headache and fever, extra strength. The patient had some lab test done about 2 or 3 week ago.  No follow-up attempts are possible. No further information is expected.
Sex: U
Vaccine: COVID19
Symptoms: Nausea, Pyrexia
Clinical narrative: Terrific headache/bad headache; I got sick last night with nausea; I got sick last night; Feel running fever and right now at 99.2; hot burn; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A patient (no qualifiers provided) received bnt162b2 (BNT162B2), administration date 17Aug2021 08:45 (Lot number: LD8448) as dose 2, single for covid-19 immunisation. Relevant medical history included: "low immune system" (unspecified if ongoing). The patient took concomitant medications. Vaccination history included: Bnt162b2 (Dose 1, Lot number: EW0164), administration date: 27Jul2021, for COVID-19 immunization; Pneumonia shot 13, for Immunization, reaction(s): "I had no side effect for the pneumonia shot". The following information was reported: HEADACHE (non-serious), outcome "unknown", described as "Terrific headache/bad headache"; NAUSEA (non-serious), outcome "unknown", described as "I got sick last night with nausea"; ILLNESS (non-serious), outcome "unknown", described as "I got sick last night"; PYREXIA (non-serious), outcome "unknown", described as "Feel running fever and right now at 99.2"; FEELING HOT (non-serious), outcome "unknown", described as "hot burn". Relevant laboratory tests and procedures are available in the appropriate section. Therapeutic measures were taken as a result of headache, nausea, illness, pyrexia, feeling hot.  Additional information: The patient got the shot that day about 8:45, somewhere around there the patient started having terrific headache and got sick last night with nausea, felt running fever and right now at 99.2. The patient was in bed. The patient wanted to know if that was normal. The patient had a low immune system. The patient was running fever right now, got a bad headache, had nausea since last night off and on and hot burn and the patient's head just felt, head hurt but head felt little relaxed. The patient took Tylenol for headache and fever, extra strength. The patient had some lab test done about 2 or 3 week ago.  No follow-up attempts are possible. No further information is expected.